[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540587":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":22,"responsibleParty":41,"collaborators":7,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":7,"enrollmentInfo":52,"targetDuration":7,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Centre Hospitalier Universitaire, Amiens","OTHER",null,[9,11],{"type":6,"name":10,"description":10,"armGroupLabels":7,"otherNames":7},"three-phase CT angiography",{"type":6,"name":12,"description":12,"armGroupLabels":7,"otherNames":7},"CEUS ultrasound",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Thierry REIX, Pr","CONTACT","03.22.08.72.65","reix.thierry@chu-amiens.fr",{"name":20,"role":16,"phone":7,"phoneExt":7,"email":21},"Gabriel IFERGAN, Dr","ifergan.gabriel@chu-amiens.fr",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"CHU Amiens Picardie","RECRUITING","Amiens","Picardie","80054","France","FR",{"type":32,"coordinates":33},"Point",[34,35],2.3,49.9,{"lat":35,"lon":34},[38],{"name":39,"role":16,"phone":40,"phoneExt":7,"email":18},"Thierry REIX, PhD","+33322455929",{"type":42,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100540587","concordance-of-three-imaging-methods-by-dynamic-ct-contrast-ultrasound-and-ct-angiography-in-the-characterization-of-endoleaks-in-patients-with-an-aortic-endoprosthesis-100540587",false,"NCT06318780","Concordance of Three Imaging Methods by Dynamic CT, Contrast Ultrasound and CT Angiography in the Characterization of Endoleaks in Patients With an Aortic Endoprosthesis","LEAKDYN","Inclusion Criteria:\n\n* Patients 18 years of age and older,\n* Patients who have received EVAR ,\n* Detection of endoleak and\u002For with an aneurysmal sac enlargement greater than or equal to 5 mm over 6 months.\n\nExclusion Criteria:\n\n* Minor patients,\n* absence of endoleak and growth of the aneurysmal sac (greater than or equal to 5 mm over 6 months),\n* patient under guardianship, curators, safeguard of justice,\n* patient deprived of liberty,\n* pregnant woman\n* Patient who does not benefit from a social security scheme","ALL","18 Years",{"count":53,"type":54},69,"ESTIMATED","INTERVENTIONAL",[57],"NA","Among patients who have undergone EVAR, there is a significant risk of 20-50% endoleak. These endoleaks often require secondary interventions to reduce the risk of expansion or rupture. Currently, three-phase CT angiography and CEUS ultrasound are recommended in the post-operative monitoring of EVAR but these remain limited in characterizing the type and source of endoleak. In this study the investigators will study the interest of d-CTA for a better detection and characterization of endoleaks.",[60],"Aortic Diseases",[62,63,64],"EVAR","d-CTA","CEUS","2025-05-21",{"date":67,"type":68},"2025-05-25","ACTUAL",{"date":70,"type":68},"2024-02-28",{"date":72,"type":54},"2031-02",{"name":5,"class":6},1]